CAPITAL: Optimal subgroup identification via constrained policy tree search

por Cai, Hengrui, Lu, Wenbin, Marceau West, Rachel, Mehrotra, Devan V., Huang, Lingkang
Publicado 2022

Identifying individual risk rare variants using protein structure guided local tests (POINT)

por Marceau West, Rachel, Lu, Wenbin, Rotroff, Daniel M., Kuenemann, Melaine A., Chang, Sheng-Mao, Wu, Michael C., Wagner, Michael J., Buse, John B., Motsinger-Reif, Alison A., Fourches, Denis, Tzeng, Jung-Ying
Publicado 2019

P1068: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER...

por Timmerman, John, Lavie, David, Johnson, Nathalie, Avigdor, Abraham, Borchmann, Peter, Andreadis, Charalambos, Bazargan, Ali, Gregory, Gareth, Keane, Colm, Tzoran, Inna, Vucinic, Vladan, Luigi Zinzani, Pier, Marceau West, Rachel, Pillai, Pallavi, Marinello, Patricia, Herrera, Alex F.
Publicado 2023

Association test using Copy Number Profile Curves (CONCUR) enhances power in rare copy number variant analysis

por Brucker, Amanda, Lu, Wenbin, Marceau West, Rachel, Yu, Qi-You, Hsiao, Chuhsing Kate, Hsiao, Tzu-Hung, Lin, Ching-Heng, Magnusson, Patrik K. E., Sullivan, Patrick F., Szatkiewicz, Jin P., Lu, Tzu-Pin, Tzeng, Jung-Ying
Publicado 2020

P1065: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY OF FAVEZELIMAB IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANTI–PD-1–NAIVE RELAPSED OR REFRACTORY CLASSICAL HODGKIN...

por Johnson, Nathalie, Lavie, David, Borchmann, Peter, Gregory, Gareth, Herrera, Alex F., Minuk, Leonard, Vucinic, Vladan, Armand, Philippe, Avigdor, Abraham, Gasiorowski, Robin, Herishanu, Yair, Keane, Colm, Kuruvilla, John, Marceau West, Rachel, Pillai, Pallavi, Marinello, Patricia, Timmerman, John
Publicado 2023